Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net income (loss)	$ 2,516	$ 2,662	$ 1,595
Adjustments to reconcile net income (loss) to cash flows from operating activities:
Impairments and other charges	116	0	366
Depreciation, depletion and amortization	1,079	998	940
Deferred Income Taxes and Tax Credits	148	196	70
Changes in assets and liabilities:
Receivables	(312)	(257)	(1,151)
Accounts payable	62	49	852
Inventories	147	(303)	(642)
Other operating activities	109	113	212
Total cash flows provided by operating activities	3,865	3,458	2,242
Cash flows from investing activities:
Capital expenditures	(1,442)	(1,379)	(1,011)
Proceeds from sales of property, plant and equipment	223	195	200
Other investing activities	(211)	(114)	(81)
Total cash flows used in investing activities	(1,654)	(1,659)	(967)
Cash flows from financing activities:
Dividends to shareholders	(600)	(576)	(435)
Proceeds from issuance of common stock	105	136	229
Stock repurchase program	(1,005)	(800)	(250)
Payments on long-term borrowings	(100)	(305)	(1,242)
Other financing activities	(130)	(126)	(100)
Total cash flows used in financing activities	(1,730)	(1,671)	(1,798)
Cash and equivalents at beginning of year	2,264
Cash and equivalents at end of year	2,618	2,264
Cash payments (receipts) during the period for:
Interest	441	460	487
Income taxes	538	616	354
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	354	(82)	(698)
Cash and equivalents	2,618	2,264	2,346	$ 3,044
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	(127)	(210)	(175)
Payments to Acquire Marketable Securities	(438)	(492)	(75)
Proceeds from Sale and Maturity of Marketable Securities	$ 214	$ 131	$ 0